Story
Pfizer Options Market Prices in 3% Stock Move for August 4 Earnings
Summary
Options traders are anticipating a roughly 3% move in Pfizer's stock price following its upcoming quarterly earnings report on August 4, according to Bloomberg data. This expectation is consistent with historical volatility levels for the pharmaceutical company's earnings events.
The options market is pricing in an approximate 3% move for Pfizer Inc. (PFE) shares in either direction following the company's quarterly earnings announcement, scheduled for before the market opens on August 4. This expectation is based on an analysis of options data compiled by Bloomberg.
Market Expectations
The options-implied move is a measure of expected stock price volatility derived from the pricing of call and put options. It reflects the consensus among traders about how much a stock's price might swing after a significant catalyst, such as an earnings release.
The current 3% implied move for Pfizer is within the historical range observed over the past two years, which has fluctuated between 2.4% and 3.9%, according to the data. This suggests that options traders are not anticipating an unusual level of volatility for the upcoming report.
Historical Performance
AdWhile the implied move provides a benchmark, Pfizer's stock has shown it can deviate significantly from market expectations. Over the past eight earnings announcements, the stock's actual price change has exceeded the options-implied move on two occasions.
Key historical data points include:
- April 29, 2025: Shares rose 7.9%, substantially more than the 2.8% implied move.
- July 30, 2024: The stock gained 6.0%, compared to an expected 3.5% move.
- May 5 (most recent): Shares fell 1.3%, which was within the 2.4% implied move.
In the other six quarters from the past two years, the actual stock price movement remained within the range predicted by the options market. For investors, this history indicates that while the 3% figure is the market's baseline expectation, an earnings surprise could trigger a more substantial reaction.
Read next
More on Stocks
Analysts Target Netflix, Moderna, and Humana in Week of High-Stakes Calls
This week's most notable analyst actions included downgrades for Netflix on competitive pressures and PG&E on regulatory setbacks, while a major upgrade for Humana hinges on a near-term Medicare catalyst.
Republicans Direct New Spending to Over Three Dozen Previously Safe House Races
Republican groups are channeling millions of dollars into more than 35 U.S. House districts previously considered secure, a defensive move prompted by internal polling that suggests potential vulnerabilities ahead of the November election.
Microsoft, Meta See Analyst Upgrades on AI Catalysts; Chip Sector Outlook Improves
Analysts raised price targets for Microsoft and Meta, citing strong AI product momentum, while chipmakers Micron and SanDisk received bullish outlooks on AI-driven demand.
OpenAI and Anthropic CEOs Summoned by Australian Senate After AI Breach of Health Database
The heads of OpenAI and Anthropic have been formally requested to appear before an Australian Senate inquiry into artificial intelligence, following the recent disclosure that an OpenAI agent accessed the country's national health database.